Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Balestrieri

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|April 30, 2003
Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitroBeatrice Macchi, Emanuela Balestrieri, Antonio Mastino
Journal of Medical Virology|September 16, 2004
Modulation of apoptosis during HTLV-1-mediated immortalization process in vitroClaudia Matteucci, Emanuela Balestrieri, Beatrice Macchi, et al.
Antiviral Research|November 8, 2005
Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitroEmanuela Balestrieri, Maria Teresa Sciortino, Antonio Mastino, et al.
Seminars in Cancer Biology|October 15, 2018
Human endogenous retroviruses role in cancer cell stemnessClaudia Matteucci, Emanuela Balestrieri, Ayele Argaw-Denboba, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitroEmanuela Balestrieri, Giancarlo Forte, Claudia Matteucci, et al.
Journal of Medical Virology|September 27, 2013
A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptaseCaterina Frezza, Emanuela Balestrieri, Francesca Marino-Merlo, et al.
Frontiers in Oncology|April 1, 2022
Editorial: Unravelling the Role of HERVs in Cancer: Insights and New Targets for TherapyClaudia Matteucci, Emanuela Balestrieri, Tara Patricia Hurst, et al.
Microbes and Infection|September 30, 2024
Crosstalk between human endogenous retroviruses and exogenous virusesEdoardo Pizzioli, Antonella Minutolo, Emanuela Balestrieri, et al.
The New Microbiologica|October 6, 2016
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHDElisa D'Agati, Mariabernarda Pitzianti, Emanuela Balestrieri, et al.
Pathogens (Basel, Switzerland)|May 7, 2020
Antiretroviral Therapy in HTLV-1 Infection: An Updated OverviewFrancesca Marino-Merlo, Emanuela Balestrieri, Claudia Matteucci, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|April 30, 2003
Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitroBeatrice Macchi, Emanuela Balestrieri, Antonio Mastino
Journal of Medical Virology|September 16, 2004
Modulation of apoptosis during HTLV-1-mediated immortalization process in vitroClaudia Matteucci, Emanuela Balestrieri, Beatrice Macchi, et al.
Antiviral Research|November 8, 2005
Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitroEmanuela Balestrieri, Maria Teresa Sciortino, Antonio Mastino, et al.
Seminars in Cancer Biology|October 15, 2018
Human endogenous retroviruses role in cancer cell stemnessClaudia Matteucci, Emanuela Balestrieri, Ayele Argaw-Denboba, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitroEmanuela Balestrieri, Giancarlo Forte, Claudia Matteucci, et al.
Journal of Medical Virology|September 27, 2013
A novel, cell-free PCR-based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptaseCaterina Frezza, Emanuela Balestrieri, Francesca Marino-Merlo, et al.
Frontiers in Oncology|April 1, 2022
Editorial: Unravelling the Role of HERVs in Cancer: Insights and New Targets for TherapyClaudia Matteucci, Emanuela Balestrieri, Tara Patricia Hurst, et al.
Microbes and Infection|September 30, 2024
Crosstalk between human endogenous retroviruses and exogenous virusesEdoardo Pizzioli, Antonella Minutolo, Emanuela Balestrieri, et al.
The New Microbiologica|October 6, 2016
First evidence of HERV-H transcriptional activity reduction after methylphenidate treatment in a young boy with ADHDElisa D'Agati, Mariabernarda Pitzianti, Emanuela Balestrieri, et al.
Pathogens (Basel, Switzerland)|May 7, 2020
Antiretroviral Therapy in HTLV-1 Infection: An Updated OverviewFrancesca Marino-Merlo, Emanuela Balestrieri, Claudia Matteucci, et al.
Pageof 7